This article is more than 5 years old. Information may no longer be current.
Poster: Deep sclerectomy combined with phaco better than phaco-trab
Click Here to Manage Email Alerts
STOCKHOLM, Sweden — Deep sclerectomy combined with phacoemulsification is a better option than phaco-trabeculectomy in patients with glaucoma and cataract, according to a poster here.
José I. Belda, MD, and colleagues at Hospital de Torrevieja in Alicante, Spain, conducted a noncomparative retrospective study of 140 cases that underwent combined glaucoma and cataract surgery.
The study included 98 cases that underwent phaco-deep sclerectomy (phaco-DS) and 42 cases that underwent phaco-trabeculectomy, according to the poster. They analyzed data for best corrected visual acuity, IOP, number of glaucoma medications and intra and postoperative complications at 1 and 7 days, 1, 3 and 6 months and 1, 2 and 3 years postop.
The results showed mean preop IOP was 22.4 mm Hg in the phaco-DS group and 23.52 mm Hg in the phaco-trabeculectomy group. At 3 years follow-up, the mean IOP was 14.47 mm Hg in the phaco-DS group and 14.37 mm Hg in the phaco-trabeculectomy group, according to the poster.
The mean number of glaucoma medications for IOP control at 3 years postop was 0.31 in the phaco-DS group and 0.87 in the phaco-trabeculectomy group. In addition, the number and severity of complications was significantly lower (P = .003) in the phaco-DS group.
"DS combined with phaco resulted in an IOP reduction similar to that with phaco-trabeculectomy 3 years after surgery, and the effectiveness of DS was higher than trabeculectomy in the number of medications," the authors wrote. "DS combined with phaco is a better choice for patients who need simultaneous glaucoma and cataract surgery, in terms of safety and effectiveness."